title: The proteostasis boundary in misfolding diseases of membrane traffic.
abstract: Protein function is regulated by the proteostasis network (PN) [Balch, W.E., Morimoto, R.I., Dillin, A. and Kelly, J.W. (2008) Adapting proteostasis for disease intervention. Science 319, 916-919], an integrated biological system that generates and protects the protein fold. The composition of the PN is regulated by signaling pathways including the unfolded protein response (UPR), the heat-shock response (HSR), the ubiquitin proteasome system (UPS) and epigenetic programs. Mismanagement of protein folding and function during membrane trafficking through the exocytic and endocytic pathways of eukaryotic cells by the PN is responsible for a wide range of diseases that include, among others, lysosomal storage diseases, myelination diseases, cystic fibrosis, systemic amyloidoses such as light chain myeloma, and neurodegenerative diseases including Alzheimer's. Toxicity from misfolding can be cell autonomous (affect the producing cell) or cell non-autonomous (affect a non-producing cell) or both, and have either a loss-of-function or gain-of-toxic function phenotype. Herein, we review the role of the PN and its regulatory transcriptional circuitry likely to be operational in managing the protein fold and function during membrane trafficking. We emphasize the enabling principle of a 'proteostasis boundary (PB)' [Powers, E.T., Morimoto, R.T., Dillin, A., Kelly, J.W., and Balch, W.E. (2009) Biochemical and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78, 959-991]. The PB is defined by the combined effects of the kinetics and thermodynamics of folding and the kinetics of misfolding, which are linked to the variable and adjustable PN capacity found different cell types. Differences in the PN account for the versatility of protein folding and function in health, and the cellular and tissue response to mutation and environmental challenges in disease. We discuss how manipulation of the folding energetics or the PB through metabolites and pharmacological intervention provides multiple routes for restoration of biological function in trafficking disease.
authors.affiliation: Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. dhutt@scripps.edu
authors.forename: Darren M
authors.initials: DM
authors.lastname: Hutt
authors.forename: Evan T
authors.initials: ET
authors.lastname: Powers
authors.forename: William E
authors.initials: WE
authors.lastname: Balch
mesh_terms: D002462:Cell Membrane / Q000378:metabolism*; D006801:Humans; D008659:Metabolic Diseases / Q000188:drug therapy / Q000378:metabolism*; D053858:Metabolic Networks and Pathways; D019636:Neurodegenerative Diseases / Q000188:drug therapy / Q000378:metabolism*; D017510:Protein Folding; D021381:Protein Transport; D011506:Proteins / Q000378:metabolism*
chemical_list: D011506:Proteins
references.citation: Annu Rev Pathol. 2008;3:427-55
references.pmid: 18039129
references.citation: Curr Mol Med. 2008 May;8(3):157-72
references.pmid: 18473817
references.citation: Endocr Rev. 2008 May;29(3):303-16
references.pmid: 18314421
references.citation: J Clin Invest. 2005 May;115(5):1111-9
references.pmid: 15864338
references.citation: Pharmacol Rev. 2007 Sep;59(3):225-50
references.pmid: 17878512
references.citation: Nature. 2007 Nov 29;450(7170):712-6
references.pmid: 18046409
references.citation: Nature. 2006 Dec 14;444(7121):860-7
references.pmid: 17167474
references.citation: Semin Cell Dev Biol. 2007 Dec;18(6):716-31
references.pmid: 18023214
references.citation: EMBO J. 2005 Dec 7;24(23):4124-32
references.pmid: 16281052
references.citation: Cell Calcium. 2005 Sep-Oct;38(3-4):303-10
references.pmid: 16076486
references.citation: Annu Rev Biochem. 2009;78:959-91
references.pmid: 19298183
references.citation: Mol Biol Cell. 2005 Aug;16(8):3847-64
references.pmid: 15944222
references.citation: J Bioenerg Biomembr. 1997 Oct;29(5):483-90
references.pmid: 9511933
references.citation: Nature. 2008 Jul 24;454(7203):455-62
references.pmid: 18650916
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3131-6
references.pmid: 19204290
references.citation: Annu Rev Pathol. 2008;3:399-425
references.pmid: 18039139
references.citation: Adv Drug Deliv Rev. 2007 Aug 10;59(8):759-81
references.pmid: 17681635
references.citation: FEBS J. 2007 Oct;274(19):4944-50
references.pmid: 17894779
references.citation: Nature. 2006 Dec 14;444(7121):854-9
references.pmid: 17167473
references.citation: Semin Cancer Biol. 2007 Oct;17(5):363-9
references.pmid: 17555985
references.citation: Cell. 2008 Jan 11;132(1):27-42
references.pmid: 18191218
references.citation: Diabetes Metab. 2008 Feb;34 Suppl 2:S91-5
references.pmid: 18640591
references.citation: Cell Mol Life Sci. 2008 Mar;65(6):855-61
references.pmid: 18239856
references.citation: J Mol Neurosci. 2006;30(3):249-65
references.pmid: 17401151
references.citation: Prog Retin Eye Res. 2008 Jul;27(4):434-49
references.pmid: 18490186
references.citation: Science. 2006 Aug 25;313(5790):1137-40
references.pmid: 16931765
references.citation: Cell. 2008 Sep 5;134(5):769-81
references.pmid: 18775310
references.citation: Biochem J. 2008 Mar 15;410(3):439-53
references.pmid: 18290764
references.citation: Nature. 2008 Jul 24;454(7203):428-35
references.pmid: 18650913
references.citation: Endocr Rev. 2008 May;29(3):367-79
references.pmid: 18292465
references.citation: Annu Rev Biochem. 2008;77:363-82
references.pmid: 18410248
references.citation: Science. 2008 May 9;320(5877):811-4
references.pmid: 18467592
references.citation: J Clin Endocrinol Metab. 2004 Aug;89(8):3629-43
references.pmid: 15292279
references.citation: Biochemistry. 2008 Jul 1;47(26):6969-84
references.pmid: 18537267
references.citation: Science. 2008 Feb 15;319(5865):916-9
references.pmid: 18276881
references.citation: Cell. 2006 Nov 17;127(4):803-15
references.pmid: 17110338
references.citation: Biochim Biophys Acta. 2008 Apr;1783(4):535-48
references.pmid: 18093543
references.citation: Antioxid Redox Signal. 2007 Dec;9(12):2277-93
references.pmid: 17979528
references.citation: Science. 2006 Mar 10;311(5766):1471-4
references.pmid: 16469881
references.citation: Contrib Nephrol. 2007;153:195-210
references.pmid: 17075231
references.citation: Curr Opin Chem Biol. 2007 Aug;11(4):412-8
references.pmid: 17644022
references.citation: Ann N Y Acad Sci. 2007 Oct;1113:202-16
references.pmid: 17513464
references.citation: Neurosci Res. 2006 Dec;56(4):441-9
references.pmid: 17028027
references.citation: Cell. 2007 Nov 16;131(4):809-21
references.pmid: 18022373
references.citation: Nat Neurosci. 2009 Apr;12(4):379-85
references.pmid: 19287390
references.citation: Diabetes Obes Metab. 2007 Nov;9 Suppl 2:23-7
references.pmid: 17919175
references.citation: Endocr Rev. 2008 Feb;29(1):42-61
references.pmid: 18048764
references.citation: Adv Exp Med Biol. 2007;594:167-89
references.pmid: 17205684
references.citation: Ann Med. 2008;40(6):402-17
references.pmid: 19160570
references.citation: Genes Dev. 2007 Jan 15;21(2):195-205
references.pmid: 17234885
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):9849-50
references.pmid: 18632571
references.citation: Nature. 2006 Dec 14;444(7121):840-6
references.pmid: 17167471
references.citation: Pathophysiology. 2008 Aug;15(2):103-8
references.pmid: 18599274
references.citation: Nat Rev Mol Cell Biol. 2004 Oct;5(10):781-91
references.pmid: 15459659
references.citation: Nature. 2007 May 31;447(7144):550-5
references.pmid: 17476212
references.citation: Cell. 2005 Apr 8;121(1):73-85
references.pmid: 15820680
references.citation: J Lipid Res. 2007 Sep;48(9):1905-14
references.pmid: 17699733
references.citation: Curr Treat Options Oncol. 2000 Apr;1(1):83-9
references.pmid: 12057064
references.citation: Cell Calcium. 2005 Sep-Oct;38(3-4):161-9
references.pmid: 16076488
references.citation: Genes Dev. 2008 Jun 1;22(11):1427-38
references.pmid: 18519635
references.citation: Genome Res. 2008 Apr;18(4):644-52
references.pmid: 18381899
references.citation: Cell Mol Life Sci. 2004 Oct;61(19-20):2461-70
references.pmid: 15526154
references.citation: Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18525-30
references.pmid: 19011102
references.citation: Endocr Rev. 2008 May;29(3):317-33
references.pmid: 18436705
references.citation: Curr Opin Investig Drugs. 2008 Apr;9(4):371-8
references.pmid: 18393104
references.citation: Front Biosci (Landmark Ed). 2009 Jan 01;14:973-94
references.pmid: 19273112
references.citation: J Intern Med. 2007 Jan;261(1):5-16
references.pmid: 17222164
references.citation: Cell Death Differ. 2009 Jan;16(1):39-45
references.pmid: 18617899
references.citation: BMC Biochem. 2007 Nov 22;8 Suppl 1:S11
references.pmid: 18047735
references.citation: Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
references.pmid: 17565364
references.citation: Int Rev Cell Mol Biol. 2008;267:59-124
references.pmid: 18544497
references.citation: Proc Natl Acad Sci U S A. 2007 May 22;104(21):8685-90
references.pmid: 17502601
references.citation: Biochem J. 2008 Jul 1;413(1):29-36
references.pmid: 18361776
references.citation: Mol Endocrinol. 2008 Feb;22(2):477-84
references.pmid: 17916655
references.citation: Nat Rev Genet. 2009 Mar;10(3):173-83
references.pmid: 19204719
references.citation: Annu Rev Biophys. 2008;37:289-316
references.pmid: 18573083
references.citation: Trends Biochem Sci. 2007 Nov;32(11):520-8
references.pmid: 17962019
references.citation: Annu Rev Biochem. 2008;77:701-26
references.pmid: 18304008